DEVELOPMENT PROJECT--PET Imaging of tumor Vasculature with 18F VEGF
$78,715P50FY2009CANIH
Stanford University, Stanford CA
Investigators
Linked publications & trials
Paper 38302473Paper 37940685Paper 34733130Paper 33104454Paper 32857284Paper 32485165Paper 30908328Paper 30373750Paper 30043654Paper 30034761Paper 29675250Paper 29631121Paper 29330552Paper 28824716Paper 28595014Paper 28572504Paper 28566692Paper 28316028Paper 28283654Paper 28280965Paper 28247187Paper 28100832Paper 27981179Paper 27858030Paper 27722328Paper 27668795Paper 27399868Paper 27394161Paper 27332865Paper 27308957Paper 27154508Paper 27031832Paper 26966191Paper 26963495Paper 26773769Paper 26695865Paper 26491079Paper 26460685Paper 26440059Paper 26313342Paper 26307602Paper 26247171Paper 26106142Paper 26106136Paper 26091827Paper 26061425Paper 26045308Paper 26035453Paper 25972517Paper 25964345Paper 25923788Paper 25908832Paper 25865775Paper 25854506Paper 25825602Paper 25800807Paper 25762106Paper 25734548Paper 25713388Paper 25613536Paper 25597243Paper 25560068Paper 25500766Paper 25429349Paper 25423651Paper 25381339Paper 25376906Paper 25320008Paper 25292385Paper 25277604Paper 25225633Paper 25188396Paper 25157764Paper 25140557Paper 25064553Paper 25033883Paper 25033190Paper 24992373Paper 24976119Paper 24972326Paper 24927395Paper 24890832Paper 24865401Paper 24850845Paper 24848238Paper 24791942Paper 24758555Paper 24727688Paper 24717098Paper 24668903Paper 24658645Paper 24645771Paper 24627435Paper 24584119Paper 24533647Paper 24524409Paper 24514041Paper 24510011Paper 24497977Paper 24495038
Abstract
This developmental project will allow Dr. Blankenberg to develop tracers for PET imaging of angiogenesis with 18F-VEGF. He has developed a SPECT based approach for imaging angiogenesis and would like to now extend this to PET so that it may have greater resolution and sensitivity for clinical imaging of tumor angiogenesis. It will also allow him to gain more experience with development of PET tracers and PET imaging. This project has good synergy with Research Project #4 (Shawn Chen PI) since that project also develops PET tracers targeted against tumor angiogenesis, but uses RDG peptides.
View original record on NIH RePORTER →